Skip to content
lifestyle.lincolnlabs.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Alligator Bioscience
Alligator Discontinues Independent Development of Mitazalimab for a Strategic Refocus on the HLX22 Project, Announces a Rights Issue of Units of Approximately SEK 125.6 Million and Raises Bridge Loans
July 23, 2026
Notice of Extraordinary General Meeting in Alligator Bioscience AB
July 23, 2026
Alligator Announces First Patient Dosed in Investigator-Initiated Study of Intratumoral Mitazalimab in Early-Stage Breast Cancer
July 2, 2026
Alligator Bioscience Comments on Henlius Update on Long-Term Follow-Up Data for HLX22
May 22, 2026
Bulletin from The Annual General Meeting in Alligator Bioscience AB on 6 May 2026
May 6, 2026
Alligator Bioscience AB Reports Financial Results for The Period 1 January – 31 March 2026 and Provides a Business Update
May 5, 2026
Invitation to Alligator Bioscience’s Earnings Call on 5 May 2026
April 28, 2026
Alligator Bioscience Comments on Henlius Presentation of HLX49 Preclinical Data at AACR 2026
April 23, 2026
New Data from Investigator‑Initiated Study Evaluating Alligator Bioscience’s Mitazalimab to Be Presented at AACR Annual Meeting 2026
April 20, 2026
Alligator Bioscience Provides an Update on Mitazalimab
April 10, 2026
1
2
Next Page
→